Van Du Nguyen

Dr. Van Du Nguyen

Chonnam National University, Gwangju, Republic of Korea
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
VNVan Du Nguyen
Van Du Nguyen
JHJi-Won Han
Ji-Won Han
YCYoung Jin Choi
Young Jin Choi
SCSunghoon Cho
Sunghoon Cho
SZShaohui Zheng
Shaohui Zheng
SPSukho Park
Sukho Park

27 June 2016 in Scientific Reports
Verified
Journal Article
Open access
JHJiwon Han
Jiwon Han
JZJin Zhen
Jin Zhen
VNVan Du Nguyen
Van Du Nguyen
GGGwangjun Go
Gwangjun Go
YCYoungjin Choi
Youngjin Choi
Sukho ParkSukho Park
Sukho Park
Using macrophage recruitment in tumors, we develop active, transportable, cancer theragnostic macrophage-based microrobots as vector to deliver therapeutic agents to tumor regions. The macrophage-based microrobots contain docetaxel (DTX)-loaded poly-lactic-co-glycolic-acid (PLGA) nanoparticles (NPs) for chemotherapy and Fe3O4 magnetic NPs (MNPs) for active targeting using an electromagnetic actuation (EMA) system. And, the macrophage-based microrobots are synthesized through the phagocytosis of the drug NPs and MNPs in the macrophages. The anticancer effects of the microrobots on tumor cell lines (CT-26 and 4T1) are evaluated in vitro by cytotoxic assay. In addition, the active tumor targeting by the EMA system and macrophage recruitment, and the chemotherapeutic effect of the microrobots are evaluated using three-dimensional (3D) tumor spheroids. The microrobots exhibited clear cytotoxicity toward tumor cells, with a low survivability rate (<50%). The 3D tumor spheroid assay showed that the microrobots demonstrated hybrid actuation through active tumor targeting by the EMA system and infiltration into the tumor spheroid by macrophage recruitment, resulting in tumor cell death caused by the delivered antitumor drug. Thus, the active, transportable, macrophage-based theragnostic microrobots can be considered to be biocompatible vectors for cancer therapy.

11 May 2021 in ACS Nano
Verified
Journal Article
Closed access
VNVan Du Nguyen
Van Du Nguyen
HMHyun-Ki Min
Hyun-Ki Min
HKHo Yong Kim
Ho Yong Kim
JHJiwon Han
Jiwon Han
YCYou Hee Choi
You Hee Choi
ECEunpyo Choi
Eunpyo Choi

1 January 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
VNVan Du Nguyen
Van Du Nguyen
HMHyun-Ki Min
Hyun-Ki Min
CKChang-Sei Kim
Chang-Sei Kim
JHJiwon Han
Jiwon Han
JPJong-Oh Park
Jong-Oh Park
ECEunpyo Choi
Eunpyo Choi

15 May 2018 in International Journal of Control, Automation, and Systems
Verified
Journal Article
Closed access
PDF file
GGGwangjun Go
Gwangjun Go
VNVan Du Nguyen
Van Du Nguyen
ZJZhen Jin
Zhen Jin
JPJong-Oh Park
Jong-Oh Park
Sukho ParkSukho Park
Sukho Park

1 December 2020 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
BDBobby Aditya Darmawan
Bobby Aditya Darmawan
SLSang Bong Lee
Sang Bong Lee
VNVan Du Nguyen
Van Du Nguyen
GGGwangjun Go
Gwangjun Go
KNKim Tien Nguyen
Kim Tien Nguyen
ECEunpyo Choi
Eunpyo Choi